HEILMITTEL UND/ODER PROPHYLACTISCHE MITTEL ZUR BEHANDLUNG VON NERVENSYSTEM-STÖRUNGEN

European patent · EP1249245 · Deleted

Register entry

Publication number
EP1249245
Application number
EP00987648
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 20, 2000
Published
Oct 16, 2002
Granted
Dec 15, 2004
Deleted
Dec 15, 2004
Reason
No effect for Switzerland and Liechtenstein
IPC classes
A61K 45/00 (2006.01)
A61K 31/4164 (2006.01)
A61K 31/4965 (2006.01)
A61K 31/55 (2006.01)
A61K 31/40 (2006.01)
A61P 43/00 (2006.01)
A61P 9/10 (2006.01)
A61P 25/28 (2006.01)
A61P 25/16 (2006.01)
A61P 25/14 (2006.01)
A61K 31/495 (2006.01)
Priority
JP 36268099 21.12.1999
JP 2000065272 09.03.2000
PCT application
PCT/JP2000/009024 20.12.2000
PCT publication
WO2001/045739 28.06.2001
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 30, 2005

    Change

    Published in +pat+ No 12 in 2005

  2. Dec 15, 2004

    Granted

    Published in +pat+ No 23 in 2004

Parties

Holder

Mitsubishi Pharma Corporation

6-9, Hiranomachi 2-chome, Chuo-ku, Osaka-shi, Osaka 541-0046, JP

Inventor

YUKI, Satoshi, Mitsubishi Pharma Corporation

Chuo-ku, Tokyo 103-8405, JP

YOSHII, Naruhiko, Mitsubishi Pharma corporation

Chuo-ku, Tokyo 103-8405, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.